Significant change:Change of product name, qualitative and quantitative composition, pharmaceutical form, indications for use, special precautions for use, adverse reactions, use during pregnancy or lactation, interactions, amounts to be administered and administration routes, pharmaceutical particulars, and MA numbers.
Date:2023-04-21
Scope:Public